Terms: = Uterine cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Diagnosis
68 results:
1. Long-Term Risk of Reintervention After Surgical Leiomyoma Treatment in an Integrated Health Care System.
Mitro SD; Xu F; Lee C; Zaritsky E; Waetjen LE; Wise LA; Hedderson MM
Obstet Gynecol; 2024 May; 143(5):619-626. PubMed ID: 38547478
[TBL] [Abstract] [Full Text] [Related]
2. Gynaecological cancer incidence and mortality trends in a Brazilian State with medium human development index: A 22-year analysis.
da Silva BEB; de Lemos LMD; Moura AR; Ferrari YAC; Lima MS; Santos MO; Lima CA
Cancer Epidemiol; 2024 Feb; 88():102493. PubMed ID: 38056244
[TBL] [Abstract] [Full Text] [Related]
3. Temporal Trend in Uptake of the National General Health Checkups and cancer Screening Program among Korean Women with Breast cancer.
Tran TXM; Kim S; Cha C; Park B
Cancer Res Treat; 2024 Apr; 56(2):522-530. PubMed ID: 37905311
[TBL] [Abstract] [Full Text] [Related]
4. Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients.
Das S; Babu A; Medha T; Ramanathan G; Mukherjee AG; Wanjari UR; Murali R; Kannampuzha S; Gopalakrishnan AV; Renu K; Sinha D; George Priya Doss C
Med Oncol; 2023 Apr; 40(5):149. PubMed ID: 37060468
[TBL] [Abstract] [Full Text] [Related]
5. Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry.
Suh DH; Ha HI; Lee YJ; Lim J; Won YJ; Lim MC
J Gynecol Oncol; 2023 Mar; 34(2):e39. PubMed ID: 36731896
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020.
Han X; Wang Z; Huang D; Deng K; Wang Q; Li C; Zhu J
BMC Womens Health; 2022 Dec; 22(1):504. PubMed ID: 36476597
[TBL] [Abstract] [Full Text] [Related]
7. Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National cancer Registry study.
Kim SI; Kim JH; Lee C; Ha J; Jung KW; Lim MC
J Gynecol Oncol; 2023 Jan; 34(1):e9. PubMed ID: 36366811
[TBL] [Abstract] [Full Text] [Related]
8. A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or cancer: The PANDA Study.
Batman S; Messick CA; Milbourne A; Guo M; Munsell MF; Fokom-Domgue J; Salcedo M; Deshmukh A; Dahlstrom KR; Ogburn M; Price A; Fleming ND; Taylor J; Shafer A; Cobb L; Sigel K; Sturgis EM; Chiao EY; Schmeler KM
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2185-2191. PubMed ID: 36126275
[TBL] [Abstract] [Full Text] [Related]
9. The Trend and Prediction of Cervical cancer Incidence in Delhi, India: An Age-Period-Cohort Analysis.
Malhotra RK; Manoharan N; Deo SS
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2787-2795. PubMed ID: 36037135
[TBL] [Abstract] [Full Text] [Related]
10. Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?
Shiri Aghbash P; Shirvaliloo M; Khalo Abass Kasho A; Alinezhad F; Nauwynck H; Bannazadeh Baghi H
Int Immunopharmacol; 2022 Jul; 108():108896. PubMed ID: 35640377
[TBL] [Abstract] [Full Text] [Related]
11. Population incidence and characteristics of secondary breast cancer after uterine cancer: a competing risk analysis.
Matsuo K; Mandelbaum R; Deshpande RR; Nusbaum DJ; Yoshihara K; Machida H; Bainvoll L; Matsuzaki S; Klar M; Roman LD; Wright JD
Arch Gynecol Obstet; 2022 Sep; 306(3):865-874. PubMed ID: 35235021
[TBL] [Abstract] [Full Text] [Related]
12. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Kashofer K; Regauer S; Reich O; Petru E; Winter E
Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
[TBL] [Abstract] [Full Text] [Related]
13. Radical Surgery After Neoadjuvant Chemotherapy for Locally Advanced Neuroendocrine cancer of the Cervix.
Caruso G; Palaia I; DI Donato V; Pernazza A; Gallo R; Perniola G; Leopizzi M; Della Rocca C; Muzii L; Panici PB
Anticancer Res; 2021 Sep; 41(9):4431-4438. PubMed ID: 34475065
[TBL] [Abstract] [Full Text] [Related]
14. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract] [Full Text] [Related]
15. Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis.
Guo M; Xu J; Du J
BMC Public Health; 2021 Jul; 21(1):1329. PubMed ID: 34229639
[TBL] [Abstract] [Full Text] [Related]
16. Cervical cancer in women under 30 years of age in Norway: a population-based cohort study.
Gravdal BH; Lönnberg S; Skare GB; Sulo G; Bjørge T
BMC Womens Health; 2021 Mar; 21(1):110. PubMed ID: 33736628
[TBL] [Abstract] [Full Text] [Related]
17. Trend analysis of process quality indicators for the Korean National Cervical cancer Screening Program from 2005 to 2013.
Bui CN; Choi E; Suh M; Jun JK; Jung KW; Lim MC; Choi KS
J Gynecol Oncol; 2021 Jan; 32(1):e14. PubMed ID: 33327046
[TBL] [Abstract] [Full Text] [Related]
18. Brain Metastases From Gynecologic Malignancies: Prevalence and Management.
Nasioudis D; Persaud A; Taunk NK; Latif NA
Am J Clin Oncol; 2020 Jun; 43(6):418-421. PubMed ID: 32235163
[TBL] [Abstract] [Full Text] [Related]
19. Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
McCool KW; Freeman ZT; Zhai Y; Wu R; Hu K; Liu CJ; Tomlins SA; Fearon ER; Magnuson B; Kuick R; Cho KR
Cancer Res; 2020 Feb; 80(4):877-889. PubMed ID: 31806642
[TBL] [Abstract] [Full Text] [Related]
20. Risk of Primary Neuroendocrine Pancreatic Tumor After a First Primary cancer: A US Population-Based Study.
Kamath GR; Kim MK; Taioli E
Pancreas; 2019 Feb; 48(2):161-168. PubMed ID: 30589832
[TBL] [Abstract] [Full Text] [Related]
[Next]
